Colistin PCD Pharma Franchise Company
Cafoli Lifecare offers a Colistin range of 2 oral dry syrup formulations, manufactured in WHO-GMP certified facilities. Distributors serving paediatric practice can secure district-wise monopoly franchise rights on this gut-selective antibiotic.
What is Colistin?
Colistin (polymyxin E) is a polymyxin antibiotic active against Gram-negative bacteria. In oral form it is minimally absorbed and acts locally within the gastrointestinal tract, making it suitable for intestinal Gram-negative infections. Compound details are available on PubChem.
Therapeutic Applications
Oral colistin dry syrup is used for Gram-negative bacterial gut infections and infective diarrhoea, particularly in children, where its non-absorbed action concentrates activity at intestinal pathogens. Prescribers are primarily paediatricians and general physicians.
Why Colistin is a High-Potential Molecule for Distributors
Bacterial diarrhoea remains a common childhood illness in India, and oral colistin dry syrup is a long-standing option for Gram-negative gut infections because it works locally without systemic exposure. This gives franchise partners steady paediatric-clinic demand, complementing ORS, zinc and probiotic lines within a childcare-focused range.
Why Choose Cafoli Lifecare
Cafoli Lifecare is a WHO-GMP compliant, DCGI-approved PCD pharma company with 1000+ franchise partners across India. Partners receive district-wise monopoly rights, promotional inputs including visual aids, MR bags and product cards, and consistent stock availability backed by quality-tested manufacturing.
References
- PubChem: Colistin
- PubMed: Oral colistin in gut infections
Our formulations of Colistin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: